These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1648851)

  • 21. Protein kinase C and the antiviral effect of human interferon.
    Cernescu C; Constantinescu SN; Baltă F; Popescu LM; Cajal N
    Virologie; 1989; 40(3):163-70. PubMed ID: 2480687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microinjection of anti-interferon antibodies into cells does not inhibit the induction of an antiviral state by interferon.
    Arnheiter H; Zoon KC
    J Virol; 1984 Oct; 52(1):284-7. PubMed ID: 6090705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antiviral effect of human interferon alpha is dependent on phosphoinositide-derived messengers.
    Cernescu C; Constantinescu SN; Baltă F; Popescu LM
    Virologie; 1988; 39(1):3-6. PubMed ID: 2837002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production, purification and biological properties of an Escherichia coli-derived recombinant porcine alpha interferon.
    Lefèvre F; L'Haridon R; Borras-Cuesta F; La Bonnardière C
    J Gen Virol; 1990 May; 71 ( Pt 5)():1057-63. PubMed ID: 1693161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of interferon on vesicular stomatitis virus proteins.
    Friedman RM; Maheshwari RK
    Nature; 1983 Apr; 302(5910):728. PubMed ID: 6300697
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhancement of viral fusion by nonadsorbing polymers.
    Herrmann A; Clague MJ; Blumenthal R
    Biophys J; 1993 Jul; 65(1):528-34. PubMed ID: 7690263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potency stability of recombinant (Serine-17) human interferon-beta.
    Geigert J; Ziegler DL; Panschar BM; Creasey AA; Vitt CR
    J Interferon Res; 1987 Apr; 7(2):203-11. PubMed ID: 3039014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous interferon (IFN) in patients with acute hepatitis B.
    Boron-Kaczmarska A; Zachoval R; Zachoval V; Deinhardt F
    Acta Med Hung; 1990; 47(1-2):77-80. PubMed ID: 1704122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiviral and anticellular activity of human leukocytic and fibroblastic interferons in homo- and heterologous cells].
    Orlova TG; Zhdanov LV; Timofeev IV; Indikova IN; Mentkevich LM
    Vopr Virusol; 1981; (4):404-7. PubMed ID: 6171095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
    tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
    J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of human leukocyte and immune interferons on the reproduction and cytopathogenic effect of the encephalomyocarditis virus in mice].
    Mentkevich LM; Zhdanova LV; Meshkova EN
    Vopr Virusol; 1984; 29(5):582-5. PubMed ID: 6097046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microtiter assay for interferon: microspectrophotometric quantitation of cytopathic effect.
    McManus NH
    Appl Environ Microbiol; 1976 Jan; 31(1):35-8. PubMed ID: 182074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New simple dye-uptake assay for interferon.
    Imanishi J; Hoshino S; Hoshino A; Oku T; Kita M; Kishida T
    Biken J; 1981 Sep; 24(3):103-8. PubMed ID: 6175308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiviral activity of murine interferons produced by bacterial and animal cell translation of messenger RNA].
    Mamontova TV; Mentkevich LM; Orlova TG
    Vopr Virusol; 1980; (1):63-7. PubMed ID: 6158177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.
    Mestan J; Brockhaus M; Kirchner H; Jacobsen H
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3113-20. PubMed ID: 2462015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion.
    Sekellick MJ; Lowenthal JW; O'Neil TE; Marcus PI
    J Interferon Cytokine Res; 1998 Jun; 18(6):407-14. PubMed ID: 9660248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation.
    François C; Bernard I; Castelain S; Charleston B; Fray MD; Capiod JC; Duverlie G
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3770-5. PubMed ID: 16127052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Methodological approaches to creating a liposomal form of human recombinant alpha 2-interferon].
    Zolin VV; Luk'ianov AN; Nesterov AE; Kolokol'tsov AA; Torchilin VP; Popov VF; Vardanian NV; Antonov NA
    Vestn Ross Akad Med Nauk; 1993; (2):29-31. PubMed ID: 7688615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renaturation of inactivated interferons: requirement for reduction of a major component; lack of requirement for reduction of a minor component.
    Stewart WE; De Somer P; De Clercq E
    J Gen Virol; 1974 Sep; 24(3):567-70. PubMed ID: 4372304
    [No Abstract]   [Full Text] [Related]  

  • 40. Two domains in alpha interferons influence the efficacy of the antiviral response.
    Zwarthoff EC; Gennissen A; Bosveld IJ; Trapman J; van Heuvel M
    Biochem Biophys Res Commun; 1987 Aug; 147(1):47-55. PubMed ID: 2820400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.